{"id":4277,"date":"2014-01-07T12:58:44","date_gmt":"2014-01-07T07:28:44","guid":{"rendered":"https:\/\/blog.fundsindia.com\/blog\/?p=4277"},"modified":"2019-06-06T19:32:30","modified_gmt":"2019-06-06T14:02:30","slug":"dr-reddys-laboratories-time-to-buy","status":"publish","type":"post","link":"https:\/\/www.fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277","title":{"rendered":"Dr.Reddy&#8217;s Laboratories: Time To Buy"},"content":{"rendered":"<p>The stocks from the pharmaceutical sector have been performing well recently. Be it the large cap ones such as Divis Lab or Lupin or the small and mid cap ones such as Dishman, Aurobindo Pharma and Shasun, the entire sector has been an outperfomer. \u00a0We take a look at Dr.Reddy&#8217;s Lab which has completed a correction and looks set to resume its uptrend.<\/p>\n<a href=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png\"><img loading=\"lazy\" class=\"alignleft size-full wp-image-4278\" src=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png\" alt=\"Drreddy\" width=\"1314\" height=\"558\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png 1314w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy-300x127.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy-1024x434.png 1024w\" sizes=\"(max-width: 1314px) 100vw, 1314px\" \/><\/a>\n<p>From the weekly chart featured above, it is clear that the stock has respected the red set of trendlines. The stock has settled comfortably above the upper red line and we now expect the uptrend to continue to the centre line of the blue pitchfork at Rs.2,700+.<\/p>\n<p>The positive view would be invalidated if Dr.Reddy&#8217;s Lab falls below Rs.2,390. Investors may use a <a href=\"http:\/\/www.fundsindia.com\/content\/jsp\/lp\/sipfund.do\" target=\"_blank\" rel=\"noopener\">SIP<\/a>-kind of approach to accumulate this stock. Beyond Rs.2,700, we would expect the stock to proceed to Rs.2,850-2,900.<\/p>\n<p>As always, patience is the key requirement in profiting from such medium to long term recommendations. Do not expect fireworks similar to the small and mid cap stocks. A steady upward progression is what we anticipate.<\/p>\n<p>(The view featured here is based on Technical Analysis of historical stock price action. Please read the Disclaimer)<\/p>\n<div class=\"blog-highlight\"><a style=\"color: #000; text-decoration: underline; font-weight: bold;\" href=\"http:\/\/www.fundsindia.com\/\/content\/jsp\/registration\/login.jsp#SignUp\" target=\"_blank\" rel=\"noopener\">Invest Now<\/a> with a <span style=\"color: #ff0000; font-weight: bold;\">FREE<\/span> FundsIndia Account<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The stocks from the pharmaceutical sector have been performing well recently. Be it the large cap ones such as Divis Lab or Lupin or the small and mid cap ones such as Dishman, Aurobindo Pharma and Shasun, the entire sector has been an outperfomer. \u00a0We take a look at Dr.Reddy&#8217;s Lab which has completed a [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[59],"tags":[140,89],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dr.Reddy&#039;s Laboratories: Time To Buy<\/title>\n<meta name=\"description\" content=\"We believe that Dr.Reddy&#039;s Laboratories could be the next stock from the pharma pack that could deliver better returns. Read the post for our target.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr.Reddy&#039;s Laboratories: Time To Buy\" \/>\n<meta property=\"og:description\" content=\"We believe that Dr.Reddy&#039;s Laboratories could be the next stock from the pharma pack that could deliver better returns. Read the post for our target.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277\" \/>\n<meta property=\"og:site_name\" content=\"Insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fundsindia\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-07T07:28:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-06-06T14:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"FundsIndia Desk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\",\"name\":\"Wealth India Financial Services\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/fundsindia\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"contentUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"width\":189,\"height\":200,\"caption\":\"Wealth India Financial Services\"},\"image\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"name\":\"Insights\",\"description\":\"Official blog of FundsIndia.com\",\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png\",\"contentUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png\",\"width\":1314,\"height\":558},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#webpage\",\"url\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277\",\"name\":\"Dr.Reddy's Laboratories: Time To Buy\",\"isPartOf\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#primaryimage\"},\"datePublished\":\"2014-01-07T07:28:44+00:00\",\"dateModified\":\"2019-06-06T14:02:30+00:00\",\"description\":\"We believe that Dr.Reddy's Laboratories could be the next stock from the pharma pack that could deliver better returns. Read the post for our target.\",\"breadcrumb\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fundsindia.com\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr.Reddy&#8217;s Laboratories: Time To Buy\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#article\",\"isPartOf\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#webpage\"},\"author\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/0ad472db6d21e4b4d8636fcadcd6712e\"},\"headline\":\"Dr.Reddy&#8217;s Laboratories: Time To Buy\",\"datePublished\":\"2014-01-07T07:28:44+00:00\",\"dateModified\":\"2019-06-06T14:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#webpage\"},\"wordCount\":214,\"commentCount\":8,\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png\",\"keywords\":[\"Dr.Reddy's Laboratories\",\"Slider\"],\"articleSection\":[\"Equity Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/0ad472db6d21e4b4d8636fcadcd6712e\",\"name\":\"FundsIndia Desk\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5c072a8111140f457e032a74732c412c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5c072a8111140f457e032a74732c412c?s=96&d=mm&r=g\",\"caption\":\"FundsIndia Desk\"},\"sameAs\":[\"http:\/\/www.fundsindia.com\"],\"url\":\"https:\/\/www.fundsindia.com\/blog\/author\/fundsindiadesk\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr.Reddy's Laboratories: Time To Buy","description":"We believe that Dr.Reddy's Laboratories could be the next stock from the pharma pack that could deliver better returns. Read the post for our target.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277","og_locale":"en_US","og_type":"article","og_title":"Dr.Reddy's Laboratories: Time To Buy","og_description":"We believe that Dr.Reddy's Laboratories could be the next stock from the pharma pack that could deliver better returns. Read the post for our target.","og_url":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277","og_site_name":"Insights","article_publisher":"https:\/\/www.facebook.com\/fundsindia","article_published_time":"2014-01-07T07:28:44+00:00","article_modified_time":"2019-06-06T14:02:30+00:00","og_image":[{"url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png"}],"twitter_misc":{"Written by":"FundsIndia Desk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/www.fundsindia.com\/blog\/#organization","name":"Wealth India Financial Services","url":"https:\/\/www.fundsindia.com\/blog\/","sameAs":["https:\/\/www.facebook.com\/fundsindia"],"logo":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#logo","inLanguage":"en-US","url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","contentUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","width":189,"height":200,"caption":"Wealth India Financial Services"},"image":{"@id":"https:\/\/www.fundsindia.com\/blog\/#logo"}},{"@type":"WebSite","@id":"https:\/\/www.fundsindia.com\/blog\/#website","url":"https:\/\/www.fundsindia.com\/blog\/","name":"Insights","description":"Official blog of FundsIndia.com","publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#primaryimage","inLanguage":"en-US","url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png","contentUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png","width":1314,"height":558},{"@type":"WebPage","@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#webpage","url":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277","name":"Dr.Reddy's Laboratories: Time To Buy","isPartOf":{"@id":"https:\/\/www.fundsindia.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#primaryimage"},"datePublished":"2014-01-07T07:28:44+00:00","dateModified":"2019-06-06T14:02:30+00:00","description":"We believe that Dr.Reddy's Laboratories could be the next stock from the pharma pack that could deliver better returns. Read the post for our target.","breadcrumb":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fundsindia.com\/blog"},{"@type":"ListItem","position":2,"name":"Dr.Reddy&#8217;s Laboratories: Time To Buy"}]},{"@type":"Article","@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#article","isPartOf":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#webpage"},"author":{"@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/0ad472db6d21e4b4d8636fcadcd6712e"},"headline":"Dr.Reddy&#8217;s Laboratories: Time To Buy","datePublished":"2014-01-07T07:28:44+00:00","dateModified":"2019-06-06T14:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#webpage"},"wordCount":214,"commentCount":8,"publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"image":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#primaryimage"},"thumbnailUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2014\/01\/Drreddy.png","keywords":["Dr.Reddy's Laboratories","Slider"],"articleSection":["Equity Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fundsindia.com\/blog\/equities\/dr-reddys-laboratories-time-to-buy\/4277#respond"]}]},{"@type":"Person","@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/0ad472db6d21e4b4d8636fcadcd6712e","name":"FundsIndia Desk","image":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/5c072a8111140f457e032a74732c412c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5c072a8111140f457e032a74732c412c?s=96&d=mm&r=g","caption":"FundsIndia Desk"},"sameAs":["http:\/\/www.fundsindia.com"],"url":"https:\/\/www.fundsindia.com\/blog\/author\/fundsindiadesk"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/4277"}],"collection":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/comments?post=4277"}],"version-history":[{"count":7,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/4277\/revisions"}],"predecessor-version":[{"id":15491,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/4277\/revisions\/15491"}],"wp:attachment":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/media?parent=4277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/categories?post=4277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/tags?post=4277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}